This topic contains a solution. Click here to go to the answer

Author Question: After you administer oral glucose to a confused and combative patient, she gradually becomes calmer ... (Read 18 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
After you administer oral glucose to a confused and combative patient, she gradually becomes calmer and fully oriented. As a knowledgeable EMT, you would recognize that the patient:
 
  A) had a high blood-sugar level.
  B) now has a decreasing blood-sugar level.
  C) will need a second dose of oral glucose.
  D) had a low blood-sugar level.

Question 2

Your 78-year-old patient gives a history of congestive heart failure, renal insufficiency, and type 2 diabetes. Together, these conditions are called:
 
  A) comorbid conditions.
  B) confounding conditions.
  C) functional impairments.
  D) polypathophysiology .



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rosiehomeworddo

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

D

Answer to Question 2

A




jparksx

  • Member
  • Posts: 570
Reply 2 on: Jul 3, 2018
Thanks for the timely response, appreciate it


tuate

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library